State Board of Administration of Florida Retirement System’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,854	Closed	-$93K	–	2428
2022 Q1	$93K	Hold	7,854	–	–	﹤0.01%	2278
2021 Q4	$256K	Hold	7,854	–	–	﹤0.01%	2130
2021 Q3	$351K	Buy	7,854 +5,495	+233%	+$268K	﹤0.01%	2027
2021 Q2	$129K	Buy	2,359 +219	+10%	+$13K	﹤0.01%	2340
2021 Q1	$160K	Hold	2,140	–	–	﹤0.01%	2256
2020 Q4	$232K	Hold	2,140	–	–	﹤0.01%	2114
2020 Q3	$189K	Hold	2,140	–	–	﹤0.01%	2086
2020 Q2	$228K	Buy	+2,140	New	+$192K	﹤0.01%	2000
2018 Q1	–	Sell	-1,241	Closed	-$121K	–	2420
2017 Q4	$121K	Buy	+1,241	New	+$167K	﹤0.01%	2340

Other funds holding SYRS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Board of Administration of Florida Retirement System's SYRS Position: Q2 2022 in Review

State Board of Administration of Florida Retirement System sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2022, closing a stake of 7,854 shares — an estimated $93K sold.

State Board of Administration of Florida Retirement System first reported a position in SYRS in Q4 2017 and held it in 9 quarters. The position peaked at $351K in Q3 2021. 67 funds tracked by Wall St. Rank hold SYRS as of Q2 2022.

State Board of Administration of Florida Retirement System reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 7,854 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $93K.
State Board of Administration of Florida Retirement System first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 9 quarters.
State Board of Administration of Florida Retirement System's Syros Pharmaceuticals, Inc. Common Stock position peaked at $351K in Q3 2021.
67 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2022, filed 5 Aug 2022.